Labopharm settles $1 million draw down under standby equity distribution... (the U.S. Canada the United Kingdom major...)

Labopharm settles $1 million draw down under standby equity distribution agreement

Date:1/8/2010

the U.S., Canada, the United Kingdom, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. and Canada and the Company has initiated the European regulatory approval process for its third product, a twice-daily formulation of tramadol-acetaminophen. Labopharm also has a pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process in various countries for the approval of the Company's products and the successful commercialization of the products throughout the world if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. Except as required by law, the Company undertakes no obligation and does not intend to update these forward-looking statements.

SOURCE Labopharm Inc.

SOURCE Labopharm Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe
2. Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
3. Labopharm Reports Results for Third Quarter Fiscal 2009
4. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
5. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
6. Labopharm submits response to FDA for novel antidepressant
7. Labopharm Reports Results for Second Quarter Fiscal 2009
8. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
9. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
10. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
11. Labopharm amends debt facility agreement with Hercules

Post Your Comments:

(Date:5/19/2013)... 19, 2013 Actos lawsuit ... now underway in U.S. District Court, Western District of ... May 3rd, the Court has modified the litigation’s Bellwether ... cases rather than four. The next Status Conference in ... 23rd. (In re: Actos Product Liability Litigation, MDL No. ...

(Date:5/19/2013)... 2013 6Webs.com is the leader in ... who are considering an alarm system can do a ... leading security system providers online at 6Webs.com. Just recently ... DIY home security system companies, 6Webs.com currently is ... of home security companies before ranking the home security ...

(Date:5/19/2013)... Americans live closer to their dogs than ever ... Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, more ... a member of the family, up from the 53.5% ... earlier. , According to the American Pet Products Association, ... to pets has increased every year without interruption, including ...

(Date:5/19/2013)... Yeast infections are common in both men and women. These ... body. A new yeast infection treatment product has been released ... of application to help eliminate over growth of the candida ... and women searching for a natural process of yeast elimination. ... and is stored in the intestines. In small consumable doses, ...

(Date:5/19/2013)... May 19, 2013 Buenos Aires, Argentina: Yoga ... offered in Buenos Aires, Argentina by the Sivananda ... de Bustamante 2372 - (Barrio Norte). Classes are 90 ... Yoga classes are offered in a calm environment, allowing ... exercises, and healthy vegetarian food, among others. , The ...

Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2 Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3 Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2 Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3 Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2 Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2

[0] Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation [0] Top Rated DIY Home Security System Companies Published by 6Webs.com [0] Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing [0] A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount [0] Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center

... areas of the brain needed to perceive feelings, study ... drinking can affect the ability to recognize other people,s ... used functional MRI to monitor brain activity in 15 ... faces with positive or negative emotional expressions. The brain ...

... treatment, prevention and detection behind progress, study finds , ... are declining, especially among younger people, new research shows. ... number one killer in the United States, topping heart ... decreased faster than for cancer. , "Older Americans have ...

... , , , , ... KAD ), a leading provider of home care, medical staffing, and pharmacy services ... ended June 30, 2009. , , For the ... with $26.8 million for the same period last year. Arcadia reported a ...

... , New England Journal of Medicine ... Could Decrease Hysterectomy Rate in United States , ... minimally invasive interventional radiology treatment for women that cuts off blood ... appropriate treatment for women in a Clinical Therapeutics article in the ...

... , , BALTIMORE, Aug. ... Maryland, the Black Nurses Association of Baltimore and the Greater ... Health Insurer Code of Conduct from the American Medical Association. ... portion of the state,s racial and ethnic minorities, including African ...

... ... Records and Direct E-mail Access to Doctors, a Growing Trend in Patient Care , ... Atlanta, GA (Vocus) August 13, 2009 ... way as one of the first physicians’ offices in Georgia to provide patients with online ...

Boozing Blunts Ability to Read Faces Cancer Deaths Declining, Especially Among Young Arcadia Resources Announces First Quarter Results Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices Atlanta Women's Specialists Raises the Bar in Patient Care With Online Medical Records and an Electronic Medical Records System

(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of their GLPG0634 ... fund and complete a Phase 2 program in Crohn,s ... Phase 3. Upon successful completion of the study, expected ... The terms of the collaboration extension are in addition ...

(Date:5/16/2013)... May 16, 2013 Nektar Therapeutics, (Nasdaq: NKTR ... Robin , is scheduled to present at the upcoming ... at the Sheraton New York Hotel on Tuesday, ... The presentation will be accessible via a Webcast through a ... the Nektar website: http://www.nektar.com . This Webcast will be ...

(Date:5/16/2013)... and SYDNEY , May 16, 2013 /PRNewswire/ ... HIN), a leading innovator of less invasive, miniaturized circulatory support ... today announced that CEO Doug Godshall ... Conference at 11:00 a.m. EDT on Monday, May 20, 2013. ... Sheraton New York Hotel. A live webcast of ...

Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2 HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2

[0] AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease [0] Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City [0] HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast

... Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ), announced today that ... Vanda,s Board of Directors. , ... "I would like to personally welcome Dr. Galson to our Board," ... of Vanda. "We are very fortunate to have a public health physician ...

... 30 Advanced Life Sciences Holdings, Inc. ... novel once-a-day oral antibiotic, today announced that it has submitted ... the proposed Phase III clinical program of Restanza in the ... Company has been engaged in the SPA process with the ...

Cached Medicine Technology:Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors 2 Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 2 Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 3 Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 4 Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia 5

Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors Advanced Life Sciences Submits Updated Special Protocol Assessment to FDA for Restanza in Community Acquired Bacterial Pneumonia

... System includes: Mx3005P instrument and ... of five (5) filters. The standard ... (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red (585nm-610nm), ... system includes notebook computer, Mx3005P analysis ...

... day-to-day temperature cycling ,Unmatched ... ,30% reduction in cycling ... coolant-based cyclers ,4 programmable ... ,Options for oil-free and ...

... includes: Mx3005P instrument and custom filter ... (5) filters. The standard filter set ... (535nm-555nm), ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) ... computer, Mx3005P analysis software, Beacon Designer ...

... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...

Medicine Products:

Mx3005P Real-Time System (230v) with notebook computer Robocycler 40 Temperature Cycler Mx3005P Real-Time PCR System (110v) with notebook computer SmartCycler 9600 System